First monoclonal antibody treatment for COVID-19 approved for use in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has today given approval for the first monoclonal antibody treatment for the prevention and treatment of COVID-19 in the UK.From:Medicines and Healthcare products Regulatory Agency¬†and¬†The Rt Hon Sajid Javid MP Published20 August 2021 Following on from a thorough review of the evidence carried out by the MHRA,Continue reading “First monoclonal antibody treatment for COVID-19 approved for use in the UK”

VACCINE ENHANCED DISEASE or PATHOGENIC PRIMING

FOUR mechanisms of vaccine enhanced disease or VED arising after exposure to wild virus post Covid19 gene editing attempts: 1 Non neutralizing antibody-dependent enhancement leading to a more severe disease or ADE (or VADE) 2 Low quality, low quantity antibody-mediated immune enhancement leading to cytokine storm or AMIE 3 Post injection immune suppression leading toContinue reading “VACCINE ENHANCED DISEASE or PATHOGENIC PRIMING”

Good News: Even A Mild COVID Infection Develops Antibody Protection That Could Last A Lifetime

on May 26, 2021 ByArjun Walia 7 minute read IN BRIEF The Facts:A new study has found that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon. Reflect On:Should we be testing people for antibodies before giving them the vaccine? Before you begin… TakeContinue reading “Good News: Even A Mild COVID Infection Develops Antibody Protection That Could Last A Lifetime”